Related Experiment Video
Updated: May 19, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Inter-tumor heterogeneity.
Mike Cusnir1, Ludmila Cavalcante
1Mount Sinai Comprehensive Cancer Center, Miami Beach, FL USA. mike.cusnir@msmc.com
Human Vaccines & Immunotherapeutics
|August 3, 2012
Summary
Cancer research focuses on molecular biomarkers to understand tumor heterogeneity. Identifying new prognostic and predictive biomarkers is crucial for personalizing cancer therapy and improving patient outcomes.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Cancer research increasingly focuses on molecular biomarkers.
- Tumor genomic landscape exhibits significant heterogeneity.
- Histologically similar tumors can display different behaviors and therapeutic responses.
Purpose of the Study:
- To highlight the importance of biomarkers in cancer research.
- To emphasize the need for prognostic and predictive biomarkers.
- To advance the concept of personalized cancer therapy.
Main Methods:
- Review of current advances in molecular cancer studies.
- Analysis of tumor heterogeneity and its implications.
- Exploration of biomarker research in oncology.
Main Results:
- Recognition of significant differences in tumor behavior and therapy response.
- Increased interest in identifying reliable prognostic and predictive biomarkers.
- Growing focus on individualizing cancer treatment strategies.
Conclusions:
- Biomarkers are essential for understanding cancer's natural course.
- Prognostic and predictive biomarkers are key to personalized medicine.
- Future cancer therapy will likely be highly individualized based on molecular data.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...